These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7613073)

  • 21. Sequence-specific inhibition of gene expression in intact human skin by epicutaneous application of chimeric antisense oligodeoxynucleotides.
    Wingens M; Pfundt R; van Vlijmen-Willems IM; van Hooijdonk CA; van Erp PE; Schalkwijk J
    Lab Invest; 1999 Nov; 79(11):1415-24. PubMed ID: 10576212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Ras p21 synthesis by antisense undecamers with uniform and specifically arranged phosphorothioate linkages.
    Rait A; Uhlmann E; Peyman A; Will DW; Chang EH
    Anticancer Drugs; 2000 Mar; 11(3):181-91. PubMed ID: 10831277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
    Alt M; Renz R; Hofschneider PH; Paumgartner G; Caselmann WH
    Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
    Chavany C; Connell Y; Neckers L
    Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides.
    Jachimczak P; Hessdörfer B; Fabel-Schulte K; Wismeth C; Brysch W; Schlingensiepen KH; Bauer A; Blesch A; Bogdahn U
    Int J Cancer; 1996 Jan; 65(3):332-7. PubMed ID: 8575854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel function of phosphorothioate oligodeoxynucleotides as chemoattractants for primary macrophages.
    Baek KH; Ha SJ; Sung YC
    J Immunol; 2001 Sep; 167(5):2847-54. PubMed ID: 11509631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides.
    Skorski T; Nieborowska-Skorska M; Wlodarski P; Perrotti D; Hoser G; Kawiak J; Majewski M; Christensen L; Iozzo RV; Calabretta B
    J Natl Cancer Inst; 1997 Jan; 89(2):124-33. PubMed ID: 8998181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo inhibition of hepatitis B virus gene expression by antisense phosphorothioate oligonucleotides.
    Moriya K; Matsukura M; Kurokawa K; Koike K
    Biochem Biophys Res Commun; 1996 Jan; 218(1):217-23. PubMed ID: 8573134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: implications for the treatment of Burkitt's lymphoma.
    Williams SA; Gillan ER; Knoppel E; Buzby JS; Suen Y; Cairo MS
    Ann Oncol; 1997; 8 Suppl 1():25-30. PubMed ID: 9187425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction with dithiothreitol causes serglycin-specific defects in secretory granule integrity of bone marrow derived mast cells.
    Braga T; Ringvall M; Tveit H; Abrink M; Pejler G
    Mol Immunol; 2009 Jan; 46(3):422-8. PubMed ID: 19059647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is antisense an appropriate nomenclature or design for oligodeoxynucleotides aimed at the inhibition of HIV-1 replication?
    Lavigne C; Yelle J; Sauve G; Thierry AR
    AAPS PharmSci; 2002; 4(2):E9. PubMed ID: 12102618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisense oligodeoxyribonucleotides suppress hematologic cell growth through stepwise release of deoxyribonucleotides.
    Vaerman JL; Moureau P; Deldime F; Lewalle P; Lammineur C; Morschhauser F; Martiat P
    Blood; 1997 Jul; 90(1):331-9. PubMed ID: 9207469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of bcr-abl oligodeoxynucleotides on the clonogenic growth of chronic myelogenous leukaemia cells.
    de Fabritiis P; Skorski T; De Propris MS; Paggi MG; Nieborowska-Skorska M; Lisci A; Buffolino S; Campbell K; Geiser T; Calabretta B
    Leukemia; 1997 Jun; 11(6):811-9. PubMed ID: 9177433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of mouse hepatitis virus multiplication by phosphorothioate analogues of oligodeoxynucleotides complementary to the leader RNA.
    Hayashi M; Maeda A; Watanabe T; Hanaki K; Arai S; Nozaki S
    J Vet Med Sci; 1995 Dec; 57(6):1081-3. PubMed ID: 8720052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells.
    Hatta T; Takai K; Nakada S; Yokota T; Takaku H
    Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hairpin extensions enhance the efficacy of mycolyl transferase-specific antisense oligonucleotides targeting Mycobacterium tuberculosis.
    Harth G; Zamecnik PC; Tabatadze D; Pierson K; Horwitz MA
    Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7199-204. PubMed ID: 17438292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
    Cucco C; Calabretta B
    Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor regression by combination antisense therapy against Plk1 and Bcl-2.
    Elez R; Piiper A; Kronenberger B; Kock M; Brendel M; Hermann E; Pliquett U; Neumann E; Zeuzem S
    Oncogene; 2003 Jan; 22(1):69-80. PubMed ID: 12527909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration.
    Biro S; Fu YM; Yu ZX; Epstein SE
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):654-8. PubMed ID: 8421701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards the selection of phosphorothioate aptamers optimizing in vitro selection steps with phosphorothioate nucleotides.
    Andreola ML; Calmels C; Michel J; Toulmé JJ; Litvak S
    Eur J Biochem; 2000 Aug; 267(16):5032-40. PubMed ID: 10931185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.